We are upgrading the repository! The content freeze has been extended to December 11, 2024, when we expect the new repository to become available. New submissions or changes to existing items will not be allowed until after the new website goes live. All content already published will remain publicly available for searching and downloading. Updates will be posted in the Website Upgrade 2024 FAQ in the sidebar Help menu. Reach out to escholarship@umassmed.edu with any questions.

Show simple item record

dc.contributor.authorLee, Kai-Fai
dc.contributor.authorLau, Kin-Mang
dc.contributor.authorHo, Shuk-Mei
dc.date2022-08-11T08:09:00.000
dc.date.accessioned2022-08-23T16:15:01Z
dc.date.available2022-08-23T16:15:01Z
dc.date.issued2000-01-06
dc.date.submitted2008-10-15
dc.identifier.citationToxicol Appl Pharmacol. 1999 Dec 15;161(3):294-301. <a href="http://dx.doi.org/10.1006/taap.1999.8821 ">Link to article on publisher's site</a>
dc.identifier.issn0041-008X (Print)
dc.identifier.doi10.1006/taap.1999.8821
dc.identifier.pmid10620487
dc.identifier.urihttp://hdl.handle.net/20.500.14038/34000
dc.description.abstractTwo trans-acting hammerhead ribozymes (Rzs), Rz1-2 and Rz4-9, were designed and shown to be effective in cleaving rat or mouse metallothenein (MT)-I and MT-II mRNA, respectively, at position +147/148, in a sequence-specific manner. The catalytic efficiency for Rz1-2 on rat MT-I was found to be 678 M(-1)s(-1) and that for Rz4-9 on rat MT-II cRNA was found to be 372 M(-1)s(-1). An expression vector, pRz(4-9/1-2), containing both Rzs linked in tandem, was constructed and used to transfect NbE-1 cells, an immortalized ventral prostate epithelial cell line. Two stable-transfected lines, NbE-1(Rz2) and NbE-1(Rz3), expressing substantial levels of (Rz1-2/Rz4-9) and minimal levels of MT-I and MT-II transcripts were found to exhibit increased sensitivity to cadmium (Cd)-induced cytotoxicity compared to the parent line. This article is the first to report successful degradation of rodent MT mRNA in vitro and in cellulo by hammerhead Rzs.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10620487&dopt=Abstract">Link to article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1006/taap.1999.8821
dc.titleGeneration and characterization of hammerhead ribozymes targeting rodent metallothionein-I and -II ribonucleic acid
dc.typeJournal Article
dc.source.journaltitleToxicology and applied pharmacology
dc.source.volume161
dc.source.issue3
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/gsbs_sp/653
dc.identifier.contextkey651123
html.description.abstract<p>Two trans-acting hammerhead ribozymes (Rzs), Rz1-2 and Rz4-9, were designed and shown to be effective in cleaving rat or mouse metallothenein (MT)-I and MT-II mRNA, respectively, at position +147/148, in a sequence-specific manner. The catalytic efficiency for Rz1-2 on rat MT-I was found to be 678 M(-1)s(-1) and that for Rz4-9 on rat MT-II cRNA was found to be 372 M(-1)s(-1). An expression vector, pRz(4-9/1-2), containing both Rzs linked in tandem, was constructed and used to transfect NbE-1 cells, an immortalized ventral prostate epithelial cell line. Two stable-transfected lines, NbE-1(Rz2) and NbE-1(Rz3), expressing substantial levels of (Rz1-2/Rz4-9) and minimal levels of MT-I and MT-II transcripts were found to exhibit increased sensitivity to cadmium (Cd)-induced cytotoxicity compared to the parent line. This article is the first to report successful degradation of rodent MT mRNA in vitro and in cellulo by hammerhead Rzs.</p>
dc.identifier.submissionpathgsbs_sp/653
dc.contributor.departmentDepartment of Surgery
dc.contributor.departmentMorningside Graduate School of Biomedical Sciences
dc.source.pages294-301


This item appears in the following Collection(s)

Show simple item record